AI Summary An insulin test measures the hormone your pancreas makes to move sugar into cells, and the blood is usually drawn after fasting. High levels can signal insulin resistance, a key driver of fatty liver and a risk factor for MASLD. Ranges vary by lab, so doctors read results with fasting glucose and HbA1c and may calculate HOMA-IR. Next steps can include liver imaging, pioglitazone, weight loss, and a liver-friendly diet.
Source: www.liverdirectory.com
Medically reviewed content.
Insulin is a blood test that measures the level of insulin, a hormone made by the pancreas that helps your cells take in and use glucose (blood sugar). Unlike fasting glucose or HbA1c, which reflect blood sugar itself, an insulin test looks at how hard your pancreas is working to keep that sugar under control.
Insulin resistance — when cells in the muscles, fat, and liver stop responding normally to insulin — is one of the central drivers of fat buildup in the liver. Because of this link, insulin testing is sometimes used alongside fasting glucose and HbA1c to evaluate MASLD (metabolic dysfunction-associated steatotic liver disease) risk.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
FASTING INSULIN BLOOD TEST
Insulin is a hormone made by beta cells in the pancreas. After you eat, insulin signals your muscle, fat, and liver cells to take in glucose from the blood and use it for energy or store it for later. This keeps blood sugar within a normal range.
An insulin blood test measures how much of this hormone is circulating, usually after fasting. It is not as commonly ordered as fasting glucose or HbA1c, but a doctor may use it to look more closely at how well insulin is working in the body, not just what your blood sugar level is.
When cells in the muscles, fat, and liver stop responding normally to insulin, a state called insulin resistance, the pancreas compensates by producing more insulin to keep blood sugar in range. This can raise insulin levels even while glucose still looks normal. Insulin resistance is a central driver of fat buildup in the liver, so an insulin test is sometimes used alongside fasting glucose and HbA1c when a doctor is evaluating fatty liver risk, not just diabetes risk on its own.
REASONS DOCTORS ORDER IT
Fasting glucose and HbA1c can stay in the normal range for a while even as insulin resistance develops, because the pancreas compensates by making more insulin. A doctor may order an insulin test to catch this compensatory rise earlier.
Insulin resistance or type 2 diabetes is one of the cardiometabolic risk factors used to diagnose MASLD (metabolic dysfunction-associated steatotic liver disease). Having fat in the liver plus at least one of these risk factors supports a MASLD diagnosis.
Fasting insulin is one of the two values needed to calculate HOMA-IR, a widely used estimate of insulin resistance in people who do not have diabetes. The other value is fasting glucose.
If you already have MASLD, prediabetes, or type 2 diabetes, your doctor may recheck insulin levels periodically alongside other metabolic markers to see whether your insulin resistance is improving, stable, or getting worse.
FASTING INSULIN AND HOMA-IR
Fasting insulin reference ranges vary by lab and testing method, so always compare your result to the range printed on your own report. The general pattern below reflects how results are typically interpreted.
Measures circulating insulin after 8 or more hours without food.
Typically about 2–19 microunits per milliliter (μIU/mL), though exact cutoffs vary by lab
Uncommon; may reflect very good insulin sensitivity, but very low levels can occasionally be seen in insulin-deficient states such as type 1 diabetes.
Suggests your cells are responding to insulin as expected at the time of the test.
May suggest insulin resistance, where the pancreas is producing extra insulin to keep blood sugar normal. This is a risk factor for MASLD and, over time, type 2 diabetes.
A calculated estimate of insulin resistance using fasting glucose and fasting insulin together, mainly used in people without diabetes.
Formula: (fasting glucose × fasting insulin) ÷ 22.5
Lower values generally suggest better insulin sensitivity.
There is no single universal cutoff; your doctor interprets the number alongside your other risk factors and lab's reference range.
Higher values suggest greater insulin resistance and may prompt further evaluation for MASLD or prediabetes, especially in people without other obvious risk factors.
Fasting insulin assays are not standardized the way fasting glucose or HbA1c are, so reference ranges differ between labs. Insulin is also affected by recent food intake, medications, and time of day. For these reasons, doctors usually interpret an insulin result together with fasting glucose, HbA1c, and your broader metabolic risk profile rather than relying on the insulin number alone.
MASLD, MASH, AND METABOLIC HEALTH
Insulin resistance or type 2 diabetes is one of four cardiometabolic risk factors doctors use to diagnose MASLD, along with obesity or increased waist circumference, high blood pressure, and abnormal cholesterol or triglycerides. Having fat in the liver plus at least one of these risk factors supports a MASLD diagnosis.
When cells resist insulin's normal signal, the pancreas raises insulin output to compensate. High circulating insulin then signals the liver to make more fat, which can build up as hepatic steatosis. Over time, having fat in the liver can also worsen insulin resistance, creating a cycle that is hard to break without treatment.
Because insulin resistance underlies both MASLD and type 2 diabetes, treatment often targets both conditions together. Pioglitazone, an oral medication, improves insulin sensitivity in the liver, muscle, and fat tissue and may improve certain features of MASH in selected patients, alongside weight management and lifestyle change.
Weight loss of 5% to 10% of body weight, a Mediterranean-style eating pattern, limiting added sugar, and regular physical activity can all improve how well your body responds to insulin, even before any medication is considered.
FOLLOW-UP AFTER YOUR TEST
A normal fasting insulin result is reassuring, but your doctor will still weigh it alongside fasting glucose, HbA1c, weight, blood pressure, and cholesterol, since MASLD risk depends on the overall picture, not one test alone.
An elevated result often prompts your doctor to calculate HOMA-IR and check for other cardiometabolic risk factors. If you have not already had liver imaging, they may order an ultrasound or another non-invasive test to look for fat in the liver.
If you have MASLD, prediabetes, or type 2 diabetes, your doctor may recheck insulin periodically alongside fasting glucose and HbA1c to track whether lifestyle changes or treatment are improving your insulin sensitivity over time.
A balanced, liver-friendly diet supports your liver and helps manage weight and blood sugar. The same habits that support healthy blood sugar generally support liver health too.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Find a Liver Nutritionist
Common Questions
Yes. A fasting insulin test is usually drawn after 8 or more hours without food, the same fasting window used for a fasting glucose test. Eating beforehand can raise your insulin level and make the result harder to interpret.
Yes. The pancreas can compensate for insulin resistance by producing extra insulin, which keeps fasting glucose and HbA1c in the normal range for a period of time even as insulin resistance develops. This is why an insulin test can sometimes catch a metabolic problem earlier than glucose-based tests alone.
HOMA-IR is a calculation that combines your fasting glucose and fasting insulin results to estimate insulin resistance: (fasting glucose × fasting insulin) ÷ 22.5. Your doctor or lab typically calculates it for you; you do not need to do the math yourself.
Not by itself. Insulin resistance is one of several cardiometabolic risk factors used alongside imaging that shows fat in the liver to diagnose MASLD. An elevated insulin result on its own is a risk marker, not a diagnosis, and your doctor will look at your full picture before drawing conclusions.
Fasting glucose and HbA1c measure blood sugar itself, either at one moment or averaged over months. An insulin test measures the hormone your pancreas produces to control that blood sugar, which can reveal insulin resistance before glucose-based tests show a change.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
